Biltmore Family Office’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,851
| Closed | -$220K | – | 335 |
|
|
2026
Q1 | $220K | Buy |
+2,851
| New | +$205K | 0.03% | 233 |
|
|
2025
Q3 | – | Sell |
-2,825
| Closed | -$213K | – | 294 |
|
|
2025
Q2 | $213K | Hold |
2,825
| – | – | 0.04% | 201 |
|
|
2025
Q1 | $251K | Hold |
2,825
| – | – | 0.04% | 184 |
|
|
2024
Q4 | $260K | Hold |
2,825
| – | – | 0.04% | 182 |
|
|
2024
Q3 | $319K | Hold |
2,825
| – | – | 0.05% | 167 |
|
|
2024
Q2 | $279K | Hold |
2,825
| – | – | 0.05% | 162 |
|
|
2024
Q1 | $285K | Hold |
2,825
| – | – | 0.06% | 158 |
|
|
2023
Q4 | $256K | Hold |
2,825
| – | – | 0.05% | 165 |
|
|
2023
Q3 | $219K | Hold |
2,825
| – | – | 0.05% | 173 |
|
|
2023
Q2 | $239K | Hold |
2,825
| – | – | 0.05% | 166 |
|
|
2023
Q1 | $240K | Hold |
2,825
| – | – | 0.05% | 202 |
|
|
2022
Q4 | $232K | Hold |
2,825
| – | – | 0.05% | 196 |
|
|
2022
Q3 | $203K | Hold |
2,825
| – | – | 0.05% | 163 |
|
|
2022
Q2 | $256K | Hold |
2,825
| – | – | 0.06% | 151 |
|
|
2022
Q1 | $319K | Sell |
2,825
-1,500
| -35% | -$176K | 0.07% | 146 |
|
|
2021
Q4 | $525K | Buy |
4,325
+1,500
| +53% | +$167K | 0.1% | 120 |
|
|
2021
Q3 | $287K | Hold |
2,825
| – | – | 0.07% | 148 |
|
|
2021
Q2 | $332K | Hold |
2,825
| – | – | 0.09% | 132 |
|
|
2021
Q1 | $313K | Hold |
2,825
| – | – | 0.1% | 127 |
|
|
2020
Q4 | $285K | Sell |
2,825
-1,175
| -29% | -$109K | 0.09% | 136 |
|
|
2020
Q3 | $315K | Hold |
4,000
| – | – | 0.18% | 107 |
|
|
2020
Q2 | $281K | Buy |
+4,000
| New | +$252K | 0.17% | 115 |
|
|
2020
Q1 | – | Sell |
-4,000
| Closed | -$320K | – | 186 |
|
|
2019
Q4 | $320K | Hold |
4,000
| – | – | 0.13% | 136 |
|
|
2019
Q3 | $298K | Hold |
4,000
| – | – | 0.13% | 128 |
|
|
2019
Q2 | $314K | Hold |
4,000
| – | – | 0.17% | 107 |
|
|
2019
Q1 | $306K | Hold |
4,000
| – | – | 0.16% | 116 |
|
|
2018
Q4 | $295K | Hold |
4,000
| – | – | 0.17% | 117 |
|
|
2018
Q3 | $385K | Hold |
4,000
| – | – | 0.18% | 106 |
|
|
2018
Q2 | $402K | Hold |
4,000
| – | – | 0.2% | 99 |
|
|
2018
Q1 | $425K | Hold |
4,000
| – | – | 0.19% | 112 |
|
|
2017
Q4 | $373K | Buy |
+4,000
| New | +$363K | 0.17% | 112 |
|
Other funds holding EMN
Biltmore Family Office's EMN Position: Q2 2026 in Review
Biltmore Family Office sold out of Eastman Chemical (EMN) in Q2 2026, closing a stake of 2,851 shares — an estimated $220K sold.
Biltmore Family Office first reported a position in EMN in Q4 2017 and held it in 31 quarters. The position peaked at $525K in Q4 2021. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.
- Biltmore Family Office reported no remaining Eastman Chemical position as of Q2 2026 after selling out during the quarter.
- Biltmore Family Office sold 2,851 Eastman Chemical shares in Q2 2026, an estimated $220K.
- Biltmore Family Office first reported a position in Eastman Chemical in Q4 2017 and held it in 31 quarters.
- Biltmore Family Office's Eastman Chemical position peaked at $525K in Q4 2021.
- 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.
Based on Biltmore Family Office's 13F filing for Q2 2026, filed 12 Aug 2026.